Kanada - Inggeris - Health Canada

biopharm australia pty ltd. - pentosan polysulfate sodium - solution - 100mg - pentosan polysulfate sodium 100mg - dogs

Austria - Inggeris - HMA (Heads of Medicines Agencies)

arthropharm (europe) limited - pentosan polysulfate sodium 100 mg - solution for injection - dogs non food - pentosan polysulfate

Perancis - Inggeris - HMA (Heads of Medicines Agencies)

arthropharm (europe) limited - pentosan polysulfate sodium 100 mg - solution for injection - dogs non food - pentosan polysulfate

Belanda - Inggeris - HMA (Heads of Medicines Agencies)

arthropharm (europe) limited - pentosan polysulfate sodium 100 mg - solution for injection - dogs non food - pentosan polysulfate

United Kingdom - Inggeris - HMA (Heads of Medicines Agencies)

arthropharm (europe) limited - pentosan polysulfate sodium 100 mg - solution for injection - dogs non food - pentosan polysulfate

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

chanelle pharmaceuticals manufacturing limited - pentosan polysulfate sodium - parenteral liquid/solution/suspension - pentosan polysulfate sodium mineral-sodium active 100.0 mg/ml - musculoskeletal system

New Zealand - Inggeris - Ministry for Primary Industries

biopharm australia pty ltd - sodium pentosan polysulphate - sodium pentosan polysulphate 100 g/litre - musculoskeletal modifier

New Zealand - Inggeris - Ministry for Primary Industries

biopharm australia pty ltd - sodium pentosan polysulphate - sodium pentosan polysulphate 250 g/litre - musculoskeletal modifier

Australia - Inggeris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - pentosan polysulfate sodium - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - anti-inflammatory agent | inflammatory joint disease | antipyretic | bone soreness | bruising | bursitis | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle soreness | non-infectious joint disease | osteoarthritis | platelet activity | rheumatism | sprains | strains | tendon sprains | traumatic swelling

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 1000 [usp'u] in 1 ml - heparin sodium injection is indicated for: - prophylaxis and treatment of venous thrombosis and pulmonary embolism; - prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation; - treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); - prevention of clotting in arterial and cardiac surgery; - prophylaxis and treatment of peripheral arterial embolism; - anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. the use of heparin sodium injection is contraindicated in patients: - history of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis - history of thrombocytopenia with pentosan polysulfate - known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see adverse reactions (6.1)] - in whom suitable blood coagulation tests (e.g., whole-blood clotting time, partial thromboplastin time) cannot be performed at appropriate inter